MIT MBA 2026. Background in finance, sales, and startup strategy. Pioneering microneedle technology with AI-driven personalized educational insights for women's hormonal health.
Femmli
Leverages micro need technology to track hormones continuously for perimenopause support
About
Originally called Precisia. Uses microneedle technology to continuously track hormones for perimenopause support. Founded by Daniela Campillo Valencia (MIT Sloan MBA 2026). Pivoted from contraceptive genetic testing to continuous hormone monitoring after identifying perimenopausal women as ideal beachhead market.
